CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine

Cephalalgia

Volumn 30, Issue 11, 2010, Pages 1346-1353

  Tvedskov, J F ^a,c   Tfelt Hansen, P ^a   Petersen, K A ^a   Jensen, L T ^b   Olesen, J ^a  

^a Danish Headache Center   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

calcitonin gene related peptide; glyceryl trinitrate; human headache model; migraine; nitric oxide; olcegepant

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE; OLCEGEPANT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MIGRAINE WITHOUT AURA; NAUSEA AND VOMITING; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; UNSPECIFIED SIDE EFFECT;

ADULT; CROSS-OVER STUDIES; DIPEPTIDES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NITROGLYCERIN; QUINAZOLINES; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; VASODILATOR AGENTS;

EID: 79751474564     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410363491     Document Type: Article

References (28)

1. Iversen HK, Olesen J., Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 1989 ; 38 (1). 17-24. (Pubitemid 19184833)
2. Petersen KA, Lassen LH, Birk S., Lesko L., Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 2005 ; 77 (3). 202-213. (Pubitemid 40269135)
3. Thomsen LL, Kruuse C., Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1994 ; (1). 73-80. (Pubitemid 2141297)
4. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002 ; 22 (1). 54-61. (Pubitemid 34626025)
5. The International Classification of Headache Disorders. 2 nd ed. Cephalalgia 2004 ; 24 (Suppl 1). 9-160.
6. Tvedskov JF, Iversen HK, Olesen J. A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. Cephalalgia 2004 ; 24 (10). 875-882. (Pubitemid 39319185)
7. Iovino M., Feifel U., Yong CL, Wolters JM, Wallenstein G. Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers. Cephalalgia 2004 ; 24 (8). 645-656. (Pubitemid 39061254)
8. Thomsen LL, Iversen HK Experimental and biological variation of three-dimensional transcranial Doppler measurements. J Appl Physiol 1993 ; 75 (6). 2805-2810. (Pubitemid 24008404)
9. Tvedskov JF, Thomsen LL, Thomsen LL, et al. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Cephalalgia 2004 ; 24 (12). 1076-1087. (Pubitemid 39577574)
10. Nielsen TH, Iversen HK, Tfelt-Hansen P. Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol 1990 ; 16 (8). 787-791.
11. Schifter S. Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassay. Peptides 1991 ; 12 (2). 365-369.
12. Olesen J., Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004 ; 350 (11). 1104-1110. (Pubitemid 38298990)
13. Goadsby PJ Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs 2005 ; 65 (18). 2557-2567. (Pubitemid 43049952)
14. Edvinsson L., Nilsson E., Jansen-Olesen I. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 2007 ; 150 (5). 633-640. (Pubitemid 46355559)
15. Edvinsson L., Alm R., Shaw D., et al. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 2002 ; 434 (1-2). 49-53. (Pubitemid 34033745)
16. Bates D., Ashford E., Dawson R., et al. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology 1994 ; 44 (9). 1587-1592. (Pubitemid 24286630)
17. Olesen J., Diener HC, Schoenen J., Hettiarachchi J. No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol 2004 ; 11 (10). 671-677. (Pubitemid 39389668)
18. Wei EP, Moskowitz MA, Boccalini P., Kontos HA Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992 ; 70 (6). 1313-1319.
19. Strecker T., Dux M., Messlinger K. Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 2002 ; 39 (6). 489-496. (Pubitemid 36091839)
20. Eltorp CT, Jansen-Olesen I., Hansen AJ Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide. Cephalalgia 2000 ; 20 (9). 838-844. (Pubitemid 32154566)
21. Offenhauser N., Zinck T., Hoffmann J., et al. CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia 2005 ; 25 (3). 225-236. (Pubitemid 40321716)
22. Kruuse C., Iversen HK, Jansen-Olesen I., Edvinsson L., Olesen J. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia 11 August 2009 ; [Epub ahead of print]. DOI 10.1111/j.1468-2982.2009.01963.x).
23. Read SJ, Smith MI, Hunter AJ, Parsons AA Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat. Cephalalgia 1997 ; 17 (3). 159-165. (Pubitemid 27257340)
24. Koulchitsky S., Fischer MJ, De CR, Schlechtweg PM, Messlinger K. Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat-possible implications for the pathophysiology of headaches. J Neurophysiol 2004 ; 92 (3). 1320-1328. (Pubitemid 39100634)
25. Olesen J., Iversen HK, Thomsen LL Nitric oxide super-sensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993 ; 4 (8). 1027-1030. (Pubitemid 23242637)
26. Koulchitsky S., Fischer MJ, Messlinger K. Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia 2009 ; 29 (4). 408-417.
27. Tvedskov JF, Iversen HK, Olesen J., Tfelt-Hansen P. Nitroglycerin provocation in normal subjects is not a useful human migraine model? Cephalalgia 9 September 2009 ; [Epub ahead of print]. DOI 10.1111/j.1468-2982.2009.02014.x.
28. Afridi SK, Kaube H., Goadsby PJ Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 2004 ; 110 (3). 675-680. (Pubitemid 39036799)